Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Double Stimulation (Elonva+rFSH) in luteal /follicular phase (drug)
• Conventional Stimulation (Elonva+rFSH) in follicular phase (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hospital Universitario Quiron Dexeus
  Barcelona, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human Chorionic Gonadotropin (hCG) (drug) — also listed as: OVITRELLE / PREGNYL
• Gonadotropins (drug) — also listed as: MENOPUR
• GNRH-A Triptorelin (drug) — also listed as: DECAPEPTYL
• GnRH antagonist (drug) — also listed as: CETROTIDE / ORGULATRON

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Lebanese University, faculty of sciences III
  Tripoli, North Lebanon, Lebanon
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Daily test with urine by the product (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Quanovate Tech Inc.
  San Ramon, California, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 4 IU of recombinant GH (Somatotropin ) (drug) — also listed as: (Somatotropin )

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Beni-suef university
  Banī Suwayf, Beni Suweif Governorate, Egypt
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human chorionic gonadotropin (drug) — also listed as: Ovitrelle

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ART Fertility Clinics LLC
  Abu Dhabi, United Arab Emirates
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Choriogonadotropin Alpha (drug) — also listed as: ovidrel, hCG
• biotin (dietary_supplement) — also listed as: vitamin B7
• Microcellulose filler (other) — also listed as: placebo, capsules

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Sports Medicine Research and Testing Laboratory
  Salt Lake City, Utah, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 150 IU of HMG in patients with age ≤ 35 years (drug)
• 225 IU of HMG in patients with age > 35 years (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ANDROS Day Surgery Clinic, Reproductive Medicine Unit
  Palermo, Italy
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• FE 999302 (drug) — also listed as: recombinant hCG
• Ovitrelle (drug)
• Novarel (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ferring Investigational Site
  Madrid, Spain
  Site recruitment: Not reported
• Ferring Investigational Site
  Seville, Spain
  Site recruitment: Not reported
• Ferring Investigational Site
  Valencia, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono (drug)
• rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UZ Brussel
  Brussels, Belgium
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Hormonal Therapy Agent (drug) — also listed as: recombinant human chorionic gonadotropin, recombinant FSH

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Androfert
  Campinas, São Paulo, Brazil
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human Chorionic Gonadotropin (drug) — also listed as: Epifasi

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Assiut University - Women's Health Hospital
  Asyut, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• no intervention (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Xiuxia Wang
  Shenyang, Liaoning, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• no intervention (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Xiuxia Wang
  Shenyang, Liaoning, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human Chorionic Gonadotrophin Intramuscular injection 10.000 IU (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Alexandria university
  Alexandria, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ovitrelle (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Rigshospitalet
  København Ø, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alfa (drug) — also listed as: Elonva

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GnRH agonist 0.2 mg + hCG 250 mcg (drug) — also listed as: GnRH agonist - Decapeptyl , hCG - Ovitrelle
• high dose hCG 500 mcg (drug) — also listed as: Ovitrelle

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Sheba Medical Center
  Ramat Gan, Israel
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follicle measurment (diagnostic_test)
• Ovitrelle ( Hcg 250 mcg) (drug)
• Decapeptyl ( GnRH Agonist 0.1 mg*2 ) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Sheba Medical Center
  Ramat Gan, Israel
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 10000 IU hCG (Choriomon5000 IU; IBSA) (drug) — also listed as: CHORIONIC GONADOTROPHIN 5000 U
• Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring) (drug) — also listed as: TRIPTOFEM 0.1 mg

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.